Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

United States

Denver Health and Hospital Authority, Denver, Colorado

George Washington University, Washington D.C., District of Columbia

Washington DC VA Medical Center, Washington D.C., District of Columbia

New York Harbor Healthcare System, Manhattan, New York

New York City Bureau of TB Control, New York, New York

San Antonio VA, San Antonio, Texas

Seattle King County Health Department, Seattle, Washington

Australia

Liverpool Hospital, Sydney

Paramatta Chest, Sydney

Royal Prince Alfred Hospital, Sydney

Canada

Calgary TB Clinic, Calgary, Alberta

Edmonton TB Clinic, Edmonton, Alberta

British Columbia Centre for Disease Control, Vancouver, British Columbia

Toronto Western Hospital, Toronto, Ontario

McGill University Health Centre, Montreal, Quebec

South Africa

Desmond Tutu TB Center, Stellenbosch